NCT05091346 2025-10-24A Study of E7386 in Combination With Pembrolizumab in Previously Treated Participants With Selected Solid TumorsEisai Inc.Phase 1/2 Completed89 enrolled 24 charts
NCT05620134 2024-10-15Study of JK08 in Patients with Unresectable Locally Advanced or Metastatic CancerSalubris Biotherapeutics IncPhase 1/2 Active not recruiting263 enrolled